Commercial Credit Report for Mega Lifesciences PCL

CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals. Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue. We also offer solutions that can help ease private company financial risk assessment. Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively.

A partial report preview for Mega Lifesciences PCL is shown below. Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database. To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

	Mega Lifesciences PCL
Floor 9 and 10, Ample Tower Building
120 Mu 11, Bangna-Trat Road
Phone: +66 27694222p:+66 27694222	BANGKOK, 10280 Thailand	Ticker: MEGAMEGA

Business Summary

Mega Lifesciences Public Company Limited is engaged in manufacturing, marketing, selling and distributing quality pharmaceutical, nutraceutical products and Fast-Moving Consumer Goods (FMCG). Its segments include Maxxcare distribution business, Mega We Care branded products business, and original equipment manufacturer (OEM) business. The Maxxcare distribution business markets, sells and distributes various branded prescription pharmaceutical products, OTC and FMCG products. Its services include warehouse management, collections, including assuming the liability for bad debts, and value-added services. Its Mega We Care branded products business develops, manufactures, markets and sells its own brand of nutraceutical products, prescription pharmaceutical products and OTC products. Mega We Care branded products are sold in a total of 35 countries around the world. Its manufacturing facilities in Thailand and Australia accept various production orders from third-party customers.

Scores and Ratings

FRISK^® Score	Z'' Score	PAYCE^® Score	DBT Index	Moody's Rating	Fitch Rating	DBRS Rating
Yes	Yes	-	-	-	-	-

Financials, News and Filings

Latest Statement	Last Audit	News	SEC Filings	Bankruptcy Filings	Suit & Judgment Filings	Tax Lien Filings
12/31/2023	12/31/2023	Yes	-	-	-	-

Industries

SIC Code	Description
2834	Pharmaceutical preparations
2833	Medicinal chemicals and botanical products
5122	Drugs, drug proprietaries, and druggists' sundries
5047	Medical, dental, and hospital equipment and supplies

Officers and Directors

Title	Name	Age	Title Date	Start Date
Independent Chairman of the Board	MechaiViravaidya	82	2/1/2013	2/1/2013
Chief Executive Officer, Executive Director	VivekDhawan	62	2/1/2013	2/1/2013
Independent Vice Chairman of the Board	Yim KamChi	66	4/5/2022	2/1/2013
9 additional Officers and Directors records available in full report.

General Information

Number of Employees:	5,513	(As of 12/31/2023)
Outstanding Shares:	871,869,508	(As of 12/31/2023)
Stock Exchange:	BAK
Fax Number:	+66 27694244

SITE MAP | ABOUT US | DIRECTORY | STOCK QUOTE: CRMZ | SIGN IN